| Segment Reporting [Table Text Block] |
| | | For the year ended May 31, | |
| | | 2026 | | | 2025 | | | 2024 | |
| Beverage | | | | | | | | | | | | |
| Net beverage revenue | | $ | 253,976 | | | $ | 240,595 | | | $ | 202,094 | |
| Beverage costs | | | 162,743 | | | | 147,591 | | | | 113,522 | |
| Beverage gross profit | | | 91,233 | | | | 93,004 | | | | 88,572 | |
| Cannabis | | | | | | | | | | | | |
| Net cannabis revenue | | | 268,342 | | | | 249,001 | | | | 272,798 | |
| Cannabis costs | | | 161,256 | | | | 150,005 | | | | 182,594 | |
| Cannabis gross profit | | | 107,086 | | | | 98,996 | | | | 90,204 | |
| Distribution | | | | | | | | | | | | |
| Distribution revenue | | | 327,244 | | | | 271,228 | | | | 258,740 | |
| Distribution costs | | | 286,589 | | | | 241,896 | | | | 230,596 | |
| Distribution gross profit | | | 40,655 | | | | 29,332 | | | | 28,144 | |
| Wellness | | | | | | | | | | | | |
| Wellness revenue | | | 65,892 | | | | 60,485 | | | | 55,310 | |
| Wellness costs | | | 44,425 | | | | 41,247 | | | | 38,879 | |
| Wellness gross profit | | | 21,467 | | | | 19,238 | | | | 16,431 | |
| Total | | | | | | | | | | | | |
| Total revenue | | | 915,454 | | | | 821,309 | | | | 788,942 | |
| Total costs | | | 655,013 | | | | 580,739 | | | | 565,591 | |
| Total gross profit | | $ | 260,441 | | | $ | 240,570 | | | $ | 223,351 | |
| | | For the year ended May 31, | |
| | | 2026 | | | 2025 | | | 2024 | |
| Gross profit | | $ | 260,441 | | | $ | 240,570 | | | $ | 223,351 | |
| | | | | | | | | | | | | |
| Operating expenses: | | | | | | | | | | | | |
| General and administrative | | | 203,629 | | | | 167,324 | | | | 167,358 | |
| Selling | | | 49,328 | | | | 56,039 | | | | 37,233 | |
| Amortization | | | 19,585 | | | | 88,616 | | | | 84,752 | |
| Marketing and promotion | | | 42,290 | | | | 37,048 | | | | 41,933 | |
| Research and development | | | 361 | | | | 284 | | | | 635 | |
| Change in fair value of contingent consideration | | | (15,000 | ) | | | — | | | | (15,790 | ) |
| Impairment of intangible assets and goodwill | | | — | | | | 2,096,139 | | | | — | |
| Other than temporary change in fair value of convertible notes receivable | | | — | | | | 21,661 | | | | 42,681 | |
| Litigation costs, net of recoveries | | | 3,902 | | | | 17,347 | | | | 8,251 | |
| Restructuring costs | | | 13,113 | | | | 34,283 | | | | 15,581 | |
| Transaction costs (income), net | | | 6,260 | | | | 4,534 | | | | 15,462 | |
| Total operating expenses | | | 323,468 | | | | 2,523,275 | | | | 398,096 | |
| Operating loss | | | (63,027 | ) | | | (2,282,705 | ) | | | (174,745 | ) |
| Interest expense, net | | | (23,663 | ) | | | (29,952 | ) | | | (36,433 | ) |
| Non-operating income (expense), net | | | (1,370 | ) | | | 10,284 | | | | (37,842 | ) |
| Loss before income taxes | | | (88,060 | ) | | | (2,302,373 | ) | | | (249,020 | ) |
| Income tax expense (recovery), net | | | 17,098 | | | | (121,017 | ) | | | (26,616 | ) |
| Net loss | | $ | (105,158 | ) | | $ | (2,181,356 | ) | | $ | (222,404 | ) |
| | | For the year ended May 31, | |
| | | 2026 | | | 2025 | | | 2024 | |
| Revenue from Canadian medical cannabis | | $ | 23,726 | | | $ | 24,998 | | | $ | 25,211 | |
| Revenue from Canadian adult-use cannabis | | | 236,352 | | | | 224,048 | | | | 266,846 | |
| Revenue from wholesale cannabis | | | 7,318 | | | | 18,207 | | | | 25,340 | |
| Revenue from international cannabis | | | 84,910 | | | | 63,356 | | | | 53,295 | |
| Less excise taxes | | | (83,964 | ) | | | (81,608 | ) | | | (97,894 | ) |
| Total | | $ | 268,342 | | | $ | 249,001 | | | $ | 272,798 | |
|